LPCN: Lipocine Inc. Stock

by  •  • Comments Off on LPCN: Lipocine Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.05
Enterprise Value ($M) 9.85
Book Value ($M) 21.00
Book Value / Share 3.92
Price / Book 0.76
NCAV ($M) 20.81
NCAV / Share 3.89
Price / NCAV 0.77

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.00

Liquidity (mrq)
Quick Ratio 14.75
Current Ratio 14.75

Balance Sheet (mrq) ($M)
Current Assets 22.32
Assets 22.51
Liabilities 1.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 11.20
Operating Income -1.16
Net Income 0.01
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.22
Cash from Investing 2.45
Cash from Financing 0.21

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 324 3,969 8.16
2025-04-16 869 3,282 26.48
2025-04-15 1,672 6,677 25.04
2025-04-14 790 10,421 7.58

(click for more detail)

Similar Companies
LGVN – Longeveron Inc. LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Lipocine Inc